Patient Pathfinder: Clinical Trials
Clinical Trials for Myelodysplastic Syndrome
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 171 active Myelodysplastic Syndrome trials
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Study Type: Interventional Phase 2
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
Study Type: Interventional Phase 1
A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)
Study Type: Interventional Phase 2
JSP191 (Briquilimab) in Subjects With LR-MDS
Study Type: Interventional Phase 1
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Study Type: Interventional
Cord Blood Transplant in Adults With Blood Cancers
Study Type: Interventional Phase 2
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Study Type: Interventional Phase 1
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Study Type: Interventional Phase 2
There are 171 active Myelodysplastic Syndrome trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now